1,426
Views
2
CrossRef citations to date
0
Altmetric
CONTRACEPTION

The influence of hormonal contraception on depression and female sexuality: a narrative review of the literature

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 193-201 | Received 21 Jul 2021, Accepted 06 Dec 2021, Published online: 16 Dec 2021

References

  • Grand View Research. [cited 2021 9 July]. Available from: https://www.grandviewresearch.com/industry-analysis/hormonal-contraceptive-market
  • United Nations, Department of Economic and Social Affairs. [cited 2021 9 July]. Available from: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2020/Jan/un_2019_contraceptiveusebymethod_databooklet.pdf
  • Fruzzetti F, Fidecicchi T. Hormonal contraception and depression: updated evidence and implications in clinical practice. Clin Drug Investig. 2020;40(12):1097–1106.
  • Malmborg A, Brynte L, Falk G, et al. Sexual function changes attributed to hormonal contraception use – a qualitative study of women experiencing negative effects. Eur J Contracept Reprod Health Care. 2020;25(3):169–175.
  • Do Rego JL, Seong JY, Burel D, et al. Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front Neuroendocrinol. 2009;30(3):259–301.
  • Balthazart J, Ball GF. Is brain estradiol a hormone or a neurotransmitter? Trends Neurosci. 2006;29(5):241–249.
  • Rune GM, Frotscher M. Neurosteroid synthesis in the hippocampus: role in synaptic plasticity. Neuroscience. 2005;136(3):833–842.
  • Brinton RD, Thompson RF, Foy MR, et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol. 2008;29(2):313–339.
  • Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol. 2014;35(1):8–30.
  • Frye CA. Neurosteroids-from basic research to clinical perspectives. In: Rubin, RT.; Pfaff, DW., editors. Hormones/behavior relations of clinical importance. Academic Press; San Diego: 2009. p. 395–416.
  • Toffoletto S, Lanzenberger R, Gingnell M, et al. Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review. Psychoneuroendocrinology. 2014;50:28–52.
  • Bayer J, Schultz H, Gamer M, et al. Menstrual-cycle dependent fluctuations in ovarian hormones affect emotional memory. Neurobiol Learn Mem. 2014;110:55–63.
  • Ossewaarde L, Hermans EJ, van Wingen GA, et al. Neural mechanisms underlying changes in stress-sensitivity across the menstrual cycle. Psychoneuroendocrinology. 2010;35(1):47–55.
  • Goldstein JM, Jerram M, Poldrack R, et al. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci. 2005;25(40):9309–9316.
  • Phillips ML, Drevets WC, Rauch SL, et al. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiatry. 2003;54(5):504–514.
  • Bannbers E, Gingnell M, Engman J, et al. The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition. J Affect Disord. 2012;142(1-3):347–350.
  • Joseph JE, Swearingen JE, Corbly CR, et al. Influence of estradiol on functional brain organization for working memory. Neuroimage. 2012;59(3):2923–2931.
  • Weiss EM, Schulter G, Fink A, et al. Influences of COMT and 5-HTTLPR polymorphisms on cognitive flexibility in healthy women: inhibition of prepotent responses and memory updating. PLOS One. 2014;9(1):e85506.
  • Craig MC, Fletcher PC, Daly EM, et al. Physiological variation in estradiol and brain function: a functional magnetic resonance imaging study of verbal memory across the follicular phase of the menstrual cycle. Horm Behav. 2008;53(4):503–508.
  • Konrad C, Engelien A, Schöning S, et al. The functional anatomy of semantic retrieval is influenced by gender, menstrual cycle, and sex hormones. J Neural Transm. 2008;115(9):1327–1337.
  • Abler B, Kumpfmüller D, Grön G, et al. Neural correlates of erotic stimulation under different levels of female sexual hormones. PLOS One. 2013;8(2):e54447.
  • Gingnell M, Bannbers E, Wikström J, et al. Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli. Eur Neuropsychopharmacol. 2013;23(11):1474–1483.
  • Pletzer B, Kronbichler M, Nuerk HC, et al. Hormonal contraceptives masculinize brain activation patterns in the absence of behavioral changes in two numerical tasks. Brain Res. 2014;1543:128–142.
  • Rumberg B, Baars A, Fiebach J, et al. Cycle and gender-specific cerebral activation during a verb generation task using fMRI: comparison of women in different cycle phases, under oral contraception, and men. Neurosci Res. 2010;66(4):366–371.
  • van Wingen GA, van Broekhoven F, Verkes RJ, et al. Progesterone selectively increases amygdala reactivity in women. Mol Psychiatry. 2008;13(3):325–333.
  • van Wingen GA, van Broekhoven F, Verkes RJ, et al. How progesterone impairs memory for biologically salient stimuli in healthy young women. J Neurosci. 2007;27(42):11416–11423.
  • Ghoumari AM, Baulieu EE, Schumacher M. Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience. 2005;135(1):47–58.
  • Schumacher M, Mattern C, Ghoumari A, et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog Neurobiol. 2014;113:6–39.
  • Guerra-Araiza C, Cerbón MA, Morimoto S, et al. Progesterone receptor isoforms expression pattern in the rat brain during the estrous cycle. Life Sci. 2000;66(18):1743–1752.
  • Guerra-Araiza C, Reyna-Neyra A, Salazar AM, et al. Progesterone receptor isoforms expression in the prepuberal and adult male rat brain. Brain Res Bull. 2001;54(1):13–17.
  • Guerra-Araiza C, Coyoy-Salgado A, Camacho-Arroyo I. Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res Bull. 2002;59(2):105–109.
  • Hirata S, Shoda T, Kato J, et al. Isoform/variant mRNAs for sex steroid hormone receptors in humans. Trends Endocrinol Metab. 2003;14(3):124–129.
  • Camacho-Arroyo I, Guerra-Araiza C, Cerbón MA. Progesterone receptor isoforms are differentially regulated by sex steroids in the rat forebrain. Neuroreport. 1998;9(18):3993–3996.
  • Singer CA, Figueroa-Masot XA, Batchelor RH, et al. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci. 1999;19(7):2455–2463.
  • Singh M. Ovarian hormones elicit phosphorylation of akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine. 2001;14(3):407–415.
  • Baulieu EE, Schumacher M, Koenig H, et al. Progesterone as a neurosteroid: actions within the nervous system. Cell Mol Neurobiol. 1996;16(2):143–154.
  • Pluchino N, Luisi M, Lenzi E, et al. Progesterone and progestins: effects on brain, allopregnanolone and beta-endorphin. J Steroid Biochem Mol Biol. 2006;102(1–5):205–213.
  • Bitran D, Shiekh M, McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol. 1995;7(3):171–177.
  • Bäckström T, Sanders D, Leask R, et al. Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med. 1983;45(6):503–507.
  • Frye CA. Effects and mechanisms of progestogens and androgens in ictal activity. Epilepsia. 2010;51(Suppl 3):135–140.
  • Frye CA, Rhodes ME 2009a. Female sex steroids and neuronal excitability. In: Schwartzkroin P, editor. Encyclopedia of basic epilepsy research. Volume 1, Academic Press, Oxford, pp. 477–484.
  • Devalckeneer A, Aboukais R, Bourgeois P, et al. Preliminary report of patients with meningiomas exposed to cyproterone acetate, nomegestrol acetate and chlormadinone acetate – monocentric ongoing study on progestin related meningiomas. Clin Neurol Neurosurg. 2021;210:106959.
  • Hara Y, Waters EM, McEwen BS, et al. Estrogen effects on cognitive and synaptic health over the lifecourse. Physiol Rev. 2015;95(3):785–807.
  • Mennenga SE, Gerson JE, Koebele SV, et al. Understanding the cognitive impact of the contraceptive estrogen ethinyl estradiol: tonic and cyclic administration impairs memory, and performance correlates with basal forebrain cholinergic system integrity. Psychoneuroendocrinology. 2015;54:1–13.
  • McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev. 1999;20(3):279–307.
  • Brinton RD. 17beta-Estradiol induction of filopodial growth in cultured hippocampal neurons within minutes of exposure. Mol Cell Neurosci. 1993;4(1):36–46.
  • Brinton RD, Tran J, Proffitt P, et al. 17 beta-Estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem Res. 1997;22(11):1339–1351.
  • Brinton RD, Chen S, Montoya M, et al. The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective. Neurobiol Aging. 2000;21(3):475–496.
  • Brinton RD. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn Mem. 2001;8(3):121–133.
  • Chen S, Brinton RD. Mechanisms of conjugated equine estrogen regulation of intracellular calcium in cultured rat hippocampal neurons. Soc. for Neurosci. 2000;26(II):(Abstract).
  • McEwen BS, Akama KT, Spencer-Segal JL, et al. Estrogen effects on the brain: actions beyond the hypothalamus via novel mechanisms. Behav Neurosci. 2012;126(1):4–16.
  • Murphy DD, Cole NB, Greenberger V, et al. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci. 1998;18(7):2550–2559.
  • Bimonte-Nelson HA, Nelson ME, Granholm ACE. Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain. Neuroreport. 2004;15(17):2659–2663.
  • Aguirre CC, Baudry M. Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices. Eur J Neurosci. 2009;29(3):447–454.
  • Janowsky JS. The role of androgens in cognition and brain aging in men. Neuroscience. 2006;138(3):1015–1020.
  • MacLusky NJ, Hajszan T, Prange-Kiel J, et al. Androgen modulation of hippocampal synaptic plasticity. Neuroscience. 2006;138(3):957–965.
  • Genazzani AR, Pluchino N, Freschi L, et al. Androgens and the brain maturitas. Maturitas. 2007;57(1):27–30.
  • Patchev VK, Schroeder J, Goetz F, et al. Neurotropic action of androgens: principles, mechanisms and novel targets. Exp Gerontol. 2004;39(11–12):1651–1660.
  • Vallée M, Mayo W, Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res Brain Res Rev. 2001;37(1–3):301–312.
  • Edinger KL, Frye CA. Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Behav Neurosci. 2004;118(6):1352–1364.
  • Frye CA. Hormonal influences on seizures: basic neurobiology. Int Rev Neurobiol. 2008;83:27–77.
  • Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299–2312.
  • World Health Organization. [cited 2021 9 July]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Washington, DC: American Psychiatric Association; 2013.
  • Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015;40(4):219–221.
  • Skovlund CW, Mørch LS, Kessing LV, et al. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73(11):1154–1162.
  • Graham CA, Ramos R, Bancroft J, et al. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception. 1995;52(6):363–369.
  • Wiréhn AB, Foldemo A, Josefsson A, et al. Use of hormonal contraceptives in relation to antidepressant therapy: a nationwide population-based study. Eur J Contracept Reprod Health Care. 2010;15(1):41–47.
  • Lindberg M, Foldemo A, Josefsson A, et al. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses. Eur J Contracept Reprod Health Care. 2012;17(2):106–118.
  • Duke JM, Sibbritt DW, Young AF. Is there an association between the use of oral contraception and depressive symptoms in young Australian women? Contraception. 2007;75(1):27–31.
  • Toffol E, Heikinheimo O, Koponen P, et al. Hormonal contraception and mental health: results of a population-based study. Hum Reprod. 2011;26(11):3085–3093.
  • Toffol E, Heikinheimo O, Koponen P, et al. Further evidence for lack of negative associations between hormonal contraception and mental health. Contraception. 2012;86(5):470–480.
  • Keyes KM, Cheslack-Postava K, Westhoff C, et al. Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States. Am J Epidemiol. 2013;178(9):1378–1388.
  • Gregory ST, Hall K, Quast T, et al. Hormonal contraception, depression, and academic performance among females attending college in the United States. Psychiatry Res. 2018;270:111–116.
  • Zettermark S, Perez Vicente R, Merlo J. Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: a pharmacoepidemiological study on 800 000 Swedish women. PLoS One. 2018;13(3):e0194773.
  • de Wit AE, Booij SH, Giltay EJ, et al. Association of use of oral contraceptives with depressive symptoms among adolescents and young Women. JAMA Psychiatry. 2020;77(1):52–59.
  • Anderl C, de Wit AE, Giltay EJ, et al. Association between  adolescent oral contraceptive use and future major depressive disorder: a prospective cohort study. J Child Psychol Psychiatr. 2021. doi:https://doi.org/10.1111/jcpp.13476.
  • The NewYork Times. [cited 2021 9 July]. Available from: https://www.nytimes.com/2010/04/25/opinion/25may.html
  • Casey E, Reese M, Okafor E, et al. Influence of menstrual cycle and oral contraceptive phase on spinal excitability. Pm R. 2016;8(9):860–868.
  • Nappi RE, Tiranini L. “50 Shades of sex' under hormonal contraception”. Gynecol Endocrinol. 2020;36(9):753–754.
  • Wallwiener CW, Wallwiener LM, Seeger H, et al. Are hormonal components of oral contraceptives associated with impaired female sexual function? A questionnaire-based online survey of medical students in Germany, Austria, and Switzerland. Arch Gynecol Obstet. 2015;292(4):883–890.
  • Smith NK, Jozkowski KN, Sanders SA. Hormonal contraception and female pain, orgasm and sexual pleasure. J Sex Med. 2014;11(2):462–470.
  • Greco T, Graham CA, Bancroft J, et al. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol. Contraception. 2007;76(1):8–17.
  • Higgins JA, Hoffman S, Graham CA, et al. Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women's Well-Being and Sexuality Study. Sex Health. 2008;5(4):321–330.
  • Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999;181(5 Pt 1):1263–1269.
  • Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: a review. J Sex Med. 2012;9(9):2213–2223.
  • Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90(9):5226–5233.
  • Susan R Davis SR, Roisin Worsley R, Miller KK, et al. Androgens and female sexual function and dysfunction-findings from the Fourth International Consultation of Sexual Medicine. J Sex Med. 2016;13(2):168–178.
  • Schindler AE, Campagnoli C, Druckmann R, et al. Classification and pharmacology of progestins. Maturitas. 2003;46:7–16.
  • Shepherd JE. Therapeutic options in female sexual dysfunction. J Am Pharm Assoc. 2002;42(3):479–487.
  • Strufaldi R, Pompei M, Steiner ML, et al. Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels. Contraception. 2010;82(2):147–154.
  • Huang M, Li G, Liu J, et al. Is there an association between contraception and sexual dysfunction in women? A systematic review and meta-analysis based on female sexual function index. J Sex Med. 2020;17(10):1942–1955.
  • Lawrie TA, Helmerhorst FM, Maitra NK, et al. Types of progestogens in combined oral contraception: effectiveness and side-effects. Cochrane Database Syst Rev. 2011;5:CD004861.
  • Lopez LM, Edelman A, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 2013;7:CD008815.
  • Svendal G, Berk M, Pasco JA, et al. The use of hormonal contraceptive agents and mood disorders in women. J Affect Disord. 2012;140(1):92–96.
  • Stomati M, Genazzani AD, Petraglia F, et al. Contraception as prevention and therapy: sex steroids and the brain. Eur J Contracept Reprod Health Care. 1998;3(1):21–28.
  • Mellon SH, Deschepper CF. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 1993;629(2):283–292.
  • King SR, 1, Ginsberg SD, Ishii T, et al. The steroidogenic acute regulatory protein is expressed in steroidogenic cells of the day-old brain. Endocrinology. 2004;145(10):4775–4780.
  • King SR. Emerging roles for neurosteroids in sexual behavior and function. J Androl. 2008;29(5):524–533.
  • Porcu P, Serra M, Concas A. The brain as a target of hormonal contraceptives: evidence from animal studies. Front Neuroendocrinol. 2019;55:100799.
  • Santoru F, Berretti R, Locci A, et al. Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats. Psychopharmacology. 2014;231(17):3351–3364.
  • Barbara G, Facchin F, Meschia M, et al. When love hurts. A systematic review on the effects of surgical and pharmacological treatments for endometriosis on female sexual functioning. Acta Obstet Gynecol Scand. 2017;96(6):668–687.
  • Vercellini P, Buggio L, Berlanda N, et al. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril. 2016;106(7):1552–1571.e2.
  • Vercellini P, Barbara G, Somigliana E, et al. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis. Fertil Steril. 2010;93(7):2150–2161.
  • Caruso S, Rugolo S, Agnello C, et al. Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate. J Sex Med. 2009;6(12):3376–3384.
  • Both S, Lew-Starowicz M, Luria M, et al. Hormonal contraception and female sexuality: position statements from the European Society of Sexual Medicine (ESSM). J Sex Med. 2019;16(11):1681–1695.
  • Pastor Z, Holla K, Chmel R. The influence of combined oral contraceptives on female sexual desire: a systematic review. Eur J Contracept Reprod Health Care. 2013;18(1):27–43.
  • Casey PM, MacLaughlin KL, Faubion SS. Impact of contraception on female sexual Function. J Womens Health. 2017;26(3):207–213.
  • Black A, Guilbert E, Costescu D, et al. No. 329-Canadian contraception consensus part 4 of 4 chapter 9: combined hormonal contraception. J Obstet Gynaecol Canada. 2017;39(4):229–268.
  • Graziottin A. The shorter, the better: a review of the evidence for a shorter contraceptive hormone-free interval. Eur J Contracept Reprod Health Care. 2016;21(2):93–105.
  • Casado-Espada NM, de Alarcón R, de la Iglesia-Larrad JI, et al. Hormonal contraceptives, female sexual dysfunction, and managing strategies: a review. JCM. 2019;8(6):908.
  • Gracia CR, Sammel MD, Charlesworth S, et al. Sexual function in first-time contraceptive ring and contraceptive patch users. Fertil Steril. 2010;93(1):21–28.
  • Mohamed AMM, El-Sherbiny WSM, Mostafa WAI. Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone). Int J Gynaecol Obstet. 2011;114(2):145–148.
  • Nappi RE. Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health. Gynecol Endocrinol. 2013;29(12):1015–1021.
  • Nappi RE. Association of E2v/DNG as contraceptive choice for a better quality of life of women. Minerva Ginecol. 2012;64(1):41–52.
  • Davis SR, Bitzer J, Giraldi A, et al. Change to either a non-androgenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction. J Sex Med. 2013;10(12):3069–3079.
  • Weinberger JM, Houman J, Caron AT, et al. Female sexual dysfunction: a systematic review of outcomes across various treatment modalities. Sex Med Rev. 2019;7(2):223–250.
  • Cahill L. How does hormonal contraception affect the developing human adolescent brain? Current Opinion in Behavioral Sciences. 2018;23:131–135.
  • Vigil P, Del Río JP, Carrera B, et al. Influence of sex steroid hormones on the adolescent brain and behavior: an update. Linacre Q. 2016;83(3):308–329.
  • Hankin BL, Abramson LY, Moffitt TE, et al. Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. J Abnorm Psychol. 1998;107(1):128–140.
  • Vandever MA, Kuehl TJ, Sulak PJ, et al. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens. Contraception. 2008;77(3):162–170.
  • Estrada-Camarena E, López-Rubalcava C, Vega-Rivera N, et al. Antidepressant effects of estrogens: a basic approximation. Behav Pharmacol. 2010;21(5–6):451–464.
  • Crowe M. Couple relationship problems and sexual dysfunctions: therapeutic guidelines. Adv Psychiatr Treat. 2012;18(2):154–159.
  • Hughes LD, Majekodunmi O. Hormonal contraception and suicide: a new dimension of risk. Br J Gen Pract. 2018;68(676):512–513.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.